Insulet | PODD - Assets



Insulet reported $3.47B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Abbott USD 84B 2.55B Jun/2025
Align Technology USD 6.22B 116.27M Jun/2025
AtriCure USD 608.85M 17.22M Jun/2025
Avanos Medical USD 1.04B 68.8M Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Becton, Dickinson and Co. USD 54.9B 435M Jun/2025
Boston Scientific USD 40.14B 745M Mar/2025
Cardinal Health USD 53.12B 3.25B Jun/2025
Cooper Companies USD 12.38B 36.9M Jul/2025
Dexcom USD 7.33B 575.3M Jun/2025
Edwards Lifesciences USD 13.02B 33M Mar/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Globus Medical USD 4.96B 249.94M Jun/2025
ICU Medical USD 4.11B 77.19M Jun/2025
Insulet USD 3.47B 48.1M Jun/2025
Integra LifeSciences USD 3.67B 384.85M Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Masimo USD 2.4B 109.5M Jun/2025
Medtronic USD 91.68B 1.71B Apr/2025
Merit Medical Systems USD 2.59B 118.07M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Solventum Corp 15.07B 547M Jun/2025
Stryker USD 46.33B 325M Jun/2025
Tandem Diabetes Care USD 875.74M 46.41M Jun/2025
Teleflex USD 7.38B 211.93M Jun/2025
West Pharmaceutical Services USD 3.95B 334.6M Jun/2025
Zimmer Biomet Holdings USD 22.87B 681.2M Jun/2025